Video Experimental Relacionado
Updated: Jul 26, 2026
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Quimioterapia para el tratamiento primario del osteosarcoma: eficacia en la población durante 20 años
M Gill1, M McCarthy, T Murrells
1Department of Community Medicine, University College London.
Lancet (London, England)
|March 26, 1988
Resumen
Las tasas de supervivencia para el osteosarcoma primario muestran una mejora significativa en los pacientes más jóvenes (menores de 25 años). La experiencia hospitalaria puede influir en los resultados, pero la quimioterapia no mejoró independientemente la supervivencia en este estudio.
Área de la Ciencia:
- Oncología Oncología.
- Epidemiología La epidemiología.
- La bioestadística es la bioestadística.
Sus antecedentes:
- El osteosarcoma es un raro cáncer de hueso que afecta principalmente a niños y adultos jóvenes.
- Las tasas de supervivencia para el osteosarcoma han variado históricamente, lo que ha llevado a investigar los factores que contribuyen.
- Los datos basados en la población son cruciales para comprender la efectividad del tratamiento en el mundo real.
Objetivo del estudio:
- Examinar las tendencias en las tasas de supervivencia del osteosarcoma en el tiempo.
- Identificar los factores que influyen en la supervivencia, incluida la edad, el período de tratamiento, la quimioterapia y la experiencia hospitalaria.
- Evaluar el impacto de los avances en el tratamiento en los resultados de los pacientes con osteosarcoma.
Principales métodos:
- Análisis de cohortes de supervivencia a 5 años para pacientes con osteosarcoma primario registrados entre 1963 y 1984.
- Utilizó datos del Registro de Cáncer del Támesis.
- Empleó el modelo de riesgos proporcionales de Cox para evaluar los predictores de supervivencia.
Principales resultados:
- Se observó una mejora significativa límite en la supervivencia en pacientes menores de 25 años (p=0,05).
- Se observó una tendencia significativa de mejora de la supervivencia en la cohorte más reciente de pacientes más jóvenes (p=0,02).
- La experiencia de tratamiento hospitalario mostró una posible asociación positiva con los resultados en pacientes más jóvenes (p = 0,11), aunque el sesgo de selección es una consideración. La quimioterapia no se relacionó de manera independiente con una mejor supervivencia para ningún grupo de edad.
Conclusiones:
- La mejora de las tendencias de supervivencia en pacientes más jóvenes con osteosarcoma puede estar relacionada con ensayos clínicos recientes y la selección de pacientes.
- Los datos del registro de cáncer basado en la población son esenciales para validar la eficacia de los nuevos regímenes de tratamiento del cáncer.
- Se necesitan más investigaciones y monitoreo para comprender las mejoras a largo plazo en la supervivencia del osteosarcoma.
Videos de Conceptos Relacionados
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...